Figure 2 shows a significant rise in testicular NF-κB p65 (~3.1-fold), IL-6 (~2.8-fold), and MPO (~3.4-fold) levels in rats administered with CIS alone compared to control. This evidence concerns the gene IL6 and in situ carcinoma.